Creative Biolabs provides ITS fungal absolute quantitative sequencing to measure taxon-resolved fungal load, not relative composition alone. Our integrated spike-in controls, sample quality review, ITS profiling, absolute abundance calculation, and phenotype-linked bioinformatics help fungal microbiome and antifungal teams distinguish genuine burden changes from compositional artifacts and move preclinical decisions forward with defensible quantitative evidence.
Fungal microbiome teams often need to know whether an intervention changes the amount of a taxon, yet standard ITS profiles report proportions within each sample. When total fungal biomass shifts, a higher percentage may reflect loss of neighboring taxa rather than true growth. Low biomass, matrix inhibition, variable ITS copy number, and amplification bias can further blur preclinical conclusions.
Antifungal programs, translational microbiome groups, and shared analysis platforms therefore need a design that connects sequencing reads to a defined quantitative reference while preserving transparent quality controls. Creative Biolabs provides an integrated service that aligns sampling, internal-standard strategy, ITS region selection, sequencing, absolute abundance computation, and phenotype-aware statistics so teams can compare fungal loads across cohorts with clearer biological context.
Measure loadMove beyond percentage-only profiles to copy-based, taxon-resolved comparisons.
Control variabilityTrack sample quality, internal-standard recovery, and amplification performance.
Support decisionsConnect differential fungal burden with preclinical phenotypes and interventions.
Our service is configured around the biological question, matrix, expected fungal biomass, and comparison structure. Each stage produces a traceable checkpoint so absolute abundance results can be interpreted alongside taxonomic composition rather than treated as an isolated calculation.
We review sample format, matrix risks, extraction status, concentration, purity, and integrity. A project-appropriate spike-in level and placement point are selected to support normalization while avoiding under-recovery or excessive consumption of sequencing reads.
ITS1 or ITS2 targeting is selected with regard to fungal groups of interest, sample type, read configuration, primer coverage, and expected amplicon behavior. Library QC and sequencing design are documented before data generation.
Internal-standard recovery is used to derive sample-level scaling factors and convert fungal feature counts into estimated copy-based abundance. Calculation rules, filtering thresholds, and normalization units are reported for transparent interpretation.
Denoised ASV or project-defined OTU profiles are assigned against an appropriate fungal reference database. Community composition, alpha diversity, beta diversity, and taxonomic resolution are evaluated with relevant QC context.
We compare absolute and relative results across treatment groups, time points, dose levels, or biological strata. This side-by-side view helps separate a genuine increase or decrease in fungal burden from a compositional shift.
Where study metadata are available, fungal load can be evaluated against efficacy, tolerability, inflammatory, barrier, metabolite, histology, or other preclinical endpoints using analysis plans matched to the study design.
| Study Need | Our Technical Response | Decision Enabled |
|---|---|---|
| Variable fungal biomass | Internal-standard normalization and explicit recovery QC | Compare fungal burden across samples on a consistent basis |
| Low-abundance targets | Input review, library QC, feature filtering, and detection-context reporting | Distinguish interpretable low signal from technical uncertainty |
| Antifungal intervention studies | Differential load testing by group, dose, or time point | Determine whether a taxon truly expands, contracts, or remains stable |
| Multimodal preclinical data | Association analysis with curated phenotype and study metadata | Prioritize taxa and patterns for follow-up validation |
Absolute ITS values are estimates of target-region copy abundance and should not automatically be interpreted as direct cell counts because ITS copy number, extraction recovery, and amplification efficiency can vary among fungi. We define reporting units and limitations before analysis.
We accept extracted DNA and many raw biological or environmental materials. Final acceptance criteria are confirmed during project scoping because matrix, biomass, collection method, storage history, and study design can affect the appropriate workflow.
| Concentration | Minimum 20 ng/µL |
|---|---|
| Volume | Minimum 25 µL |
| Purity | A260/280 of 1.8-2.0; A260/230 > 2.0 |
| Integrity | High-molecular-weight DNA with a clear agarose-gel band |
| Buffer | Sterile nuclease-free water or low-EDTA TE buffer |
Raw biological samples: Contact us for collection and storage guidance specific to your matrix. Rapid stabilization, immediate extraction, or storage at -80°C may be appropriate to preserve community integrity and quantitative comparability.
The workflow adapts to raw samples or extracted DNA while maintaining a consistent chain of quality review, quantitative control, sequencing, computation, and reporting.
Typical turnaround: 6-8 weeks from receipt of qualified samples, including extraction when applicable, library preparation, sequencing, bioinformatics, and reporting. Expedited options may be evaluated during consultation.
Delivery standards are aligned to the agreed analysis plan. Files, tables, graphics, methods, and interpretation are organized so research teams can trace results from read-level output to biological conclusions.
| Deliverable Component | Content Specifications |
|---|---|
| Raw Sequencing Data | Demultiplexed FASTQ files with project-level file organization and sample identifiers. |
| Processed Data Files | ASV or OTU tables with absolute abundance estimates; relative abundance tables; taxonomic assignments from kingdom to species where supported; internal-standard recovery metrics; and phylogenetic outputs when appropriate. |
| Bioinformatics Report | Executive summary, detailed methodology, QC results, fungal composition, alpha and beta diversity, differential load analysis, statistical comparisons, charts, tables, and interpretation of biological significance. |
| Optional Integrated Analysis | Associations between fungal load and supplied preclinical metadata, including treatment, time point, efficacy, safety, pathology, immune, metabolite, or other project-specific endpoints. |
Recent research has validated synthetic rRNA operons as spike-in standards for quantitative profiling of fungal and bacterial microbiomes. The standards cover ITS1 and ITS2 targets and were tested with mock communities and environmental material. The published data show that spike-in read recovery tracks the amount of reference material across a useful quantitative range, supporting conversion of compositional sequencing output into estimates of differential microbial load.
For ITS fungal studies, this evidence matters because it demonstrates how an internal reference can reveal between-sample load differences that relative abundance alone cannot resolve. The figure illustrates quantitative performance across fungal primer sets and sample inputs while also highlighting the need to select an appropriate spike level and interpret copy-based values carefully. Creative Biolabs can translate this principle into a study-specific workflow combining spike-in planning, sample quality control, ITS sequencing, taxonomic profiling, absolute abundance calculation, and phenotype-linked statistics, with documented checkpoints from sample receipt through final data review.
Creative Biolabs combines fungal microbiology, sequencing, quantitative controls, and bioinformatics in one coordinated service, helping teams preserve methodological context from sample intake through interpretation.
Absolute abundance estimates address changes in total fungal load that percentage-only profiles may conceal.
ITS targeting supports detailed fungal identification, with resolution reported only where sequence evidence permits.
Relative community structure and estimated absolute load are delivered together for more complete interpretation.
Traceable checkpoints cover input quality, standard recovery, libraries, sequencing, and bioinformatics.
Project scientists help align matrix, marker, comparison structure, statistics, and reporting with the study goal.
Optional stratification, longitudinal analysis, network exploration, and phenotype association can be scoped as needed.
Fungal ecology, environmental science, plant pathology, human health, and veterinary research requiring reproducible load-aware data.
Antifungal discovery, disease-mechanism, biomarker, therapeutic-intervention, and microbiome programs.
Soil health, crop protection, plant disease, fermentation, and spoilage investigations.
Fungal contamination, biodiversity, ecosystem response, and longitudinal surveillance studies.
Research into fungal burden and community dynamics on skin and other product-relevant surfaces.
Specialist outsourcing for high-precision fungal sequencing, calculation, and bioinformatics reporting.
Share your matrix, group design, expected biomass, and key preclinical endpoints for a tailored technical recommendation.
Extend ITS absolute quantification with broader microbial profiling, complementary research technologies, or dedicated antifungal screening and characterization.
Relative abundance can be misleading when total fungal biomass differs among samples. A taxon may occupy a larger percentage because another taxon declined, not because its own load increased. Absolute quantification provides a copy-based estimate for each detected fungal taxon, enabling more direct comparisons of burden and more defensible interpretation of treatment, disease, or environmental effects.
ITS1 and ITS2 are variable regions within the fungal ribosomal operon. Their primer coverage, amplicon length, amplification behavior, and taxonomic performance can differ across fungal groups and sample matrices. We select the target after reviewing the taxa of interest, sample type, expected DNA quality, reference-database coverage, and compatibility with the quantitative standard.
Standard analysis includes read QC, denoising or agreed OTU construction, fungal taxonomic assignment, internal-standard recovery review, absolute abundance calculation, relative abundance, alpha diversity, beta diversity, group comparisons, and a report with charts and interpretation. Differential load and phenotype association are included when supported by the study design and agreed scope.
Not automatically. ITS sequencing generally estimates target-region copy abundance, while copy number per genome can differ among fungal taxa. Extraction efficiency and amplification bias also affect the relationship between copies and cells. We define the reporting unit clearly and can discuss complementary measurements or taxon-specific calibration when direct cell-number interpretation is essential.
Please provide the sample type and count, raw material or extracted DNA status, treatment groups, time points, taxa or fungal groups of interest, anticipated biomass, collection and storage conditions, available phenotype metadata, desired comparisons, and reporting timeline. We will use these details to recommend the marker, control strategy, sequencing plan, and analysis scope.
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
Copyright © 2026 Creative Biolabs. All Rights Reserved.
